Follow us:  

  • Home
  • News&Events
  • Latest news


PPP Made In Europe consultation

EFFRA is currently preparing the strategic research and innovation agenda (SRIA) for the Made In Europe Partnership under the next Research and Innovation Framework Programme 'Horizon Europe'.

In order to lay the foundations of the Made In Europe Partnership, a guidance document has been prepared in cooperation with the Eurpean Commission. The documents reflects the need for and the ambition of this new manufacturing partnership. It describes a set of Main Objectives and associated Research & Innovation Objectives, as well as a Key Performance Indicators. This guidance document builds on the vision that was described in the document 'EFFRA vision for a manufacturing partnership in Horizon Europe' that was published in March 2019.

Currently EFFRA carries out a consultation consisting of two main tracks:

-One track aims at collecting the opinion of individual experts who respond on behalf of their organisation (or on behalf of a part of their organisation)

-The other track collects information from the perspective of finished or ongoing European Projects, in particular addressing Factories of the Future PPP projects, but not excluding other relevant projects. You can find more information about this consultation here:

second Coronavirus call for an Expression of Interest

Second Coronavirus call for an Expression of Interest (H2020-SC1-PHE-CORONAVIRUS-2020-2) is now on the Funding & Tenders Portal and submission of proposals is available to applicants. 

An online information session on this call  will take place on Wednesday 20 May 2020 from 14h00 to 16h30. You will be able to follow it via the following link for web streaming:

Please note that because of the technical limitations there will be no direct dialogue for Q&A: questions can be sent via email (only) during the relevant topic presentation to This email address is being protected from spambots. You need JavaScript enabled to view it.

The links to the 5 topics of this EoI are as follows:

  • SC1-PHE-CORONAVIRUS-2020-2A - Repurposing of manufacturing for vital medical supplies and equipment

  • SC1-PHE-CORONAVIRUS-2020-2B - Medical technologies, Digital tools and Artificial Intelligence (AI) analytics to improve surveillance and care at high Technology Readiness Levels (TRL)

  • SC1-PHE-CORONAVIRUS-2020-2C - Behavioural, social and economic impacts of the outbreak response

  • SC1-PHE-CORONAVIRUS-2020-2D - Pan-European COVID-19 cohorts

  • SC1-PHE-CORONAVIRUS-2020-2E - Networking of existing EU and international cohorts of relevance to COVID-19

The Intellectual Property implications of the development of industrial 3D printing

The aim of this Study was to analyse the IP implications of the development of industrial 3D printing and clarify how the existing IP framework brings protection to IP rights holders. It identifies potential challenges and how they can be removed and opportunities in need of clarification in order to aid the competitiveness of the AM sector in Europe.

The focus is on seven industrial applications of AM: health, aerospace, automotive, consumer goods/electronics, energy, industrial equipment and tooling and construction and building sectors. This report identifies the pertinent IP considerations according to different elements in the 3D printing process, i.e. designing a CAD file, using and sharing a CAD file, printing the CAD file, distributing the printed good and finally, licensing it.

The report can be downloaded here in several languages: